腔內縫合裝置市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測

2024 年全球腔內縫合器市場價值為 7,930 萬美元，預計 2025 年至 2034 年期間將以 17.5% 的強勁複合年成長率擴張，這得益於人們對微創手術的偏好日益增加以及胃腸道和減肥手術數量的增加。由於醫療保健提供者優先考慮患者的安全和更快的恢復時間，對先進縫合解決方案的需求持續上升。全球範圍內肥胖症的日益流行導致了減肥手術的激增，其中腔內縫合裝置在胃繞道手術和外科修復等手術中發揮著至關重要的作用。此外，包括改進的可視化、增強的可操作性和與機器人系統的整合在內的技術進步，使得這些設備更加高效、更易於使用。這種向精準手術干預的轉變極大地促進了市場擴張。

越來越多的醫療專業人員開始採用腔內縫合裝置，因為它能夠降低手術風險、縮短住院時間並改善病患治療效果。這些設備具有高精度，能夠在複雜的手術過程中實現無縫組織近似。隨著醫療機構強調感染控制和成本效益，對一次性縫合設備的需求正在激增。自動縫合系統和人工智慧手術工具的引入進一步簡化了操作，使手術更加安全、有效。此外，監管部門的批准和優惠的報銷政策正在支持市場成長，鼓勵人們採用這些創新醫療設備。

在產品類型中，一次性產品將成為主要驅動力，預計複合年成長率為 17.2%，到 2034 年將達到 2.03 億美元。這些設備在外科手術中更受青睞，因為它們能夠消除交叉污染風險並減少感染相關的併發症。它們的便利性，加上無需消毒，大大降低了營運成本，同時確保符合嚴格的衛生標準。尤其是醫院和門診手術中心，正在採用一次性腔內縫合裝置來提高效率和病人安全。隨著醫療保健行業轉向一次性解決方案以滿足監管和安全要求，這些先進設備的需求預計將激增。

胃腸道缺陷應用領域預計將顯著成長，預計複合年成長率為 17.6%，到 ​​2034 年將達到 1.696 億美元。潰瘍、穿孔和瘻管等胃腸道疾病發病率的增加推動了對微創治療方案的需求。許多此類疾病源自於慢性疾病和生活方式相關因素，需要有效的手術介入。腔內縫合裝置為此類複雜病例提供了精確、微創的解決方案，提高了患者的康復率並減少了術後併發症。人們越來越關注透過先進的縫合技術加強胃腸道護理，這進一步推動了市場擴張。

美國腔內縫合器市場預計將大幅成長，2024 年價值估計將達到 2,740 萬美元。肥胖率上升和胃腸道疾病盛行率上升是推動需求的關鍵因素。隨著減重手術越來越受歡迎以及對慢性胃腸道疾病創新治療的需求不斷成長，腔內縫合裝置正成為全國各地外科醫生的首選。人口老化加上生活方式的轉變，進一步加速了對這些設備的需求。隨著手術技術的不斷進步和對微創手術的大力投入，美國市場預計將在塑造腔內縫合解決方案的未來方面發揮關鍵作用。

目錄

第 1 章：方法論與範圍

第 2 章：執行摘要

第 3 章：產業洞察

• 產業生態系統分析
• 產業衝擊力
  • 成長動力
    • 全球慢性病盛行率上升
    • 微創手術的需求不斷增加
    • 技術進步
    • 老年人口不斷增加
  • 產業陷阱與挑戰
    • 嚴格的監管環境
    • 缺乏熟練的醫療保健專業人員
• 成長潛力分析
• 監管格局
• 技術格局
• 差距分析
• 波特的分析
• PESTEL 分析
• 未來市場趨勢
• 價值鏈分析

第4章：競爭格局

• 介紹
• 公司矩陣分析
• 主要市場參與者的競爭分析
• 競爭定位矩陣
• 策略儀表板

第 5 章：市場估計與預測：按產品類型，2021 年至 2034 年

• 主要趨勢
• 一次使用
• 可重複使用的

第 6 章：市場估計與預測：按應用，2021 年至 2034 年

• 主要趨勢
• 胃腸道缺陷
• 減重手術
• 胃食道逆流症（GERD）
• 其他應用

第 7 章：市場估計與預測：依最終用途，2021 年至 2034 年

• 主要趨勢
• 醫院
• 門診手術中心
• 其他最終用戶

第 8 章：市場估計與預測：按地區，2021 年至 2034 年

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 荷蘭
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第9章：公司簡介

• Apollo Endosurgery
• Boston Scientific
• Braun Melsungen
• Cook Group
• Endo Tools Therapeutics
• ErgoSuture
• Johnson and Johnson
• Karl Storz
• Medtronic
• Olympus Corporation
• Ovesco Endoscopy
• Richard Wolf
• Teleflex Corporation
• Terumo Corporation
• USGI Medical

The Global Endoluminal Suturing Devices Market, valued at USD 79.3 million in 2024, is projected to expand at a robust CAGR of 17.5% from 2025 to 2034., driven by the increasing preference for minimally invasive surgical procedures and the rising number of gastrointestinal and bariatric surgeries. As healthcare providers prioritize patient safety and faster recovery times, the demand for advanced suturing solutions continues to rise. The growing prevalence of obesity worldwide has led to a surge in bariatric procedures, where endoluminal suturing devices play a crucial role in procedures like gastric bypass and surgical revisions. Furthermore, technological advancements, including improved visualization, enhanced maneuverability, and integration with robotic systems, are making these devices more efficient and easier to use. This shift towards precision-driven surgical interventions is significantly contributing to market expansion.

Medical professionals are increasingly embracing endoluminal suturing devices due to their ability to reduce surgical risks, shorten hospital stays, and improve patient outcomes. These devices offer high accuracy, enabling seamless tissue approximation in complex surgical procedures. As healthcare facilities emphasize infection control and cost-efficiency, the demand for disposable, single-use suturing devices is surging. The introduction of automated suturing systems and AI-driven surgical tools is further streamlining operations, making procedures safer and more effective. Additionally, regulatory approvals and favorable reimbursement policies are supporting market growth, encouraging the adoption of these innovative medical devices.

Among product types, the single-use segment is set to be a key driver, with a projected CAGR of 17.2%, reaching an estimated USD 203 million by 2034. These devices are preferred in surgical settings due to their ability to eliminate cross-contamination risks and reduce infection-related complications. Their convenience, combined with the elimination of sterilization requirements, significantly lowers operational costs while ensuring compliance with stringent hygiene standards. Hospitals and ambulatory surgical centers, in particular, are embracing single-use endoluminal suturing devices to enhance efficiency and patient safety. As the healthcare industry moves towards disposable solutions to meet regulatory and safety requirements, the demand for these advanced devices is expected to surge.

The gastrointestinal defects application segment is anticipated to witness significant growth, with a projected CAGR of 17.6%, reaching USD 169.6 million by 2034. The increasing incidence of gastrointestinal conditions, including ulcers, perforations, and fistulas, is driving demand for minimally invasive treatment options. Many of these conditions stem from chronic diseases and lifestyle-related factors, necessitating effective surgical interventions. Endoluminal suturing devices provide a precise and minimally invasive solution for such complex cases, improving patient recovery rates and reducing post-surgical complications. The growing focus on enhancing gastrointestinal care through advanced suturing technologies is further fueling market expansion.

The United States endoluminal suturing devices market is poised for substantial growth, with an estimated value of USD 27.4 million in 2024. The rising obesity rates and increasing prevalence of gastrointestinal disorders are key factors driving demand. As bariatric procedures gain popularity and the need for innovative treatments for chronic gastrointestinal diseases grows, endoluminal suturing devices are becoming a preferred choice for surgeons across the country. The aging population, coupled with shifting lifestyle trends, is further accelerating the demand for these devices. With continuous advancements in surgical technology and strong investment in minimally invasive procedures, the US market is expected to play a pivotal role in shaping the future of endoluminal suturing solutions.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising prevalence of chronic disease across the globe
    • 3.2.1.2 Increasing demand for minimally invasive procedures
    • 3.2.1.3 Technological advancements
    • 3.2.1.4 Rising geriatric population
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Stringent regulatory scenario
    • 3.2.2.2 Dearth of skilled healthcare professionals
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technology landscape
• 3.6 Gap analysis
• 3.7 Porter's analysis
• 3.8 PESTEL analysis
• 3.9 Future market trends
• 3.10 Value chain analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 – 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Single use
• 5.3 Reusable

Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Gastrointestinal defects
• 6.3 Bariatric surgery
• 6.4 Gastroesophageal reflux disease (GERD)
• 6.5 Other applications

Chapter 7 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Ambulatory surgical centers
• 7.4 Other end users

Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 Apollo Endosurgery
• 9.2 Boston Scientific
• 9.3 Braun Melsungen
• 9.4 Cook Group
• 9.5 Endo Tools Therapeutics
• 9.6 ErgoSuture
• 9.7 Johnson and Johnson
• 9.8 Karl Storz
• 9.9 Medtronic
• 9.10 Olympus Corporation
• 9.11 Ovesco Endoscopy
• 9.12 Richard Wolf
• 9.13 Teleflex Corporation
• 9.14 Terumo Corporation
• 9.15 USGI Medical